Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
04 2023
Historique:
received: 27 10 2022
accepted: 13 02 2023
revised: 17 04 2023
medline: 19 4 2023
pubmed: 6 4 2023
entrez: 5 4 2023
Statut: epublish

Résumé

Investigation of potential hosts of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is crucial to understanding future risks of spillover and spillback. SARS-CoV-2 has been reported to be transmitted from humans to various animals after requiring relatively few mutations. There is significant interest in describing how the virus interacts with mice as they are well adapted to human environments, are used widely as infection models and can be infected. Structural and binding data of the mouse ACE2 receptor with the Spike protein of newly identified SARS-CoV-2 variants are needed to better understand the impact of immune system evading mutations present in variants of concern (VOC). Previous studies have developed mouse-adapted variants and identified residues critical for binding to heterologous ACE2 receptors. Here we report the cryo-EM structures of mouse ACE2 bound to trimeric Spike ectodomains of four different VOC: Beta, Omicron BA.1, Omicron BA.2.12.1 and Omicron BA.4/5. These variants represent the oldest to the newest variants known to bind the mouse ACE2 receptor. Our high-resolution structural data complemented with bio-layer interferometry (BLI) binding assays reveal a requirement for a combination of mutations in the Spike protein that enable binding to the mouse ACE2 receptor.

Identifiants

pubmed: 37018380
doi: 10.1371/journal.ppat.1011206
pii: PPATHOGENS-D-22-01858
pmc: PMC10109501
doi:

Substances chimiques

Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
ACE2 protein, human EC 3.4.17.23
Ace2 protein, mouse EC 3.4.17.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011206

Informations de copyright

Copyright: © 2023 Ni et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors declare no competing interests in regards to this work.

Références

J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Virol. 2021 Mar 10;95(11):
pubmed: 33692203
Nat Commun. 2021 Dec 20;12(1):7345
pubmed: 34930910
Nat Microbiol. 2022 Aug;7(8):1161-1179
pubmed: 35798890
Proc Biol Sci. 2021 Nov 24;288(1963):20211651
pubmed: 34784766
Nat Chem. 2021 Oct;13(10):963-968
pubmed: 34413500
Nat Rev Microbiol. 2017 Aug;15(8):502-510
pubmed: 28555073
Nat Commun. 2021 Sep 27;12(1):5654
pubmed: 34580297
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Virol. 2020 Oct 27;94(22):
pubmed: 32847856
Nat Struct Mol Biol. 2021 Feb;28(2):128-131
pubmed: 33402708
Nat Commun. 2021 Oct 20;12(1):6103
pubmed: 34671049
Nat Microbiol. 2022 Sep;7(9):1376-1389
pubmed: 35879526
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
Science. 2021 Aug 6;373(6555):648-654
pubmed: 34210893
Science. 2021 Aug 6;373(6555):642-648
pubmed: 34168070
Science. 2022 Jul 22;377(6604):420-424
pubmed: 35762884
J Gen Virol. 2022 Apr;103(4):
pubmed: 35377298
J Genet Genomics. 2021 Dec;48(12):1111-1121
pubmed: 34954396
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
J Virol. 2020 Aug 31;94(18):
pubmed: 32661139
Proc Natl Acad Sci U S A. 2021 Mar 23;118(12):
pubmed: 33658332
Cell Rep. 2022 Sep 13;40(11):111359
pubmed: 36075211
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
ACS Chem Biol. 2013 Sep 20;8(9):1925-30
pubmed: 23869965
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
PLoS Pathog. 2022 Jan 13;18(1):e1010161
pubmed: 35025969
Nature. 2013 Nov 28;503(7477):535-8
pubmed: 24172901
Nature. 2022 Aug;608(7923):593-602
pubmed: 35714668
Cell Rep. 2021 Oct 12;37(2):109814
pubmed: 34599871
Proc Natl Acad Sci U S A. 2021 Nov 2;118(44):
pubmed: 34716263
Nat Med. 2022 Sep;28(9):1785-1790
pubmed: 35760080
Pediatr Res. 2004 Jul;56(1):1-5
pubmed: 15152053
Cell Discov. 2020 Sep 29;6:68
pubmed: 33020722
Science. 2022 Feb 18;375(6582):760-764
pubmed: 35050643
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
N Engl J Med. 2020 Mar 26;382(13):1268-1269
pubmed: 32109011
J Virol. 2021 Jan 13;95(3):
pubmed: 33144321
Nat Commun. 2022 Jul 7;13(1):3921
pubmed: 35798721
J Virol. 2022 Sep 14;96(17):e0081422
pubmed: 36000849
Natl Sci Rev. 2022 Jun 23;9(9):nwac122
pubmed: 36187898
Cell Rep. 2021 Jan 12;34(2):108630
pubmed: 33417835
Cell Res. 2022 Jul;32(7):609-620
pubmed: 35641567
Nature. 2022 Apr;604(7905):330-336
pubmed: 35172323
Signal Transduct Target Ther. 2021 Dec 14;6(1):420
pubmed: 34907154
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nature. 2022 Mar;603(7903):913-918
pubmed: 35114688
Signal Transduct Target Ther. 2022 Jun 28;7(1):202
pubmed: 35764603
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Virus Res. 2008 Apr;133(1):74-87
pubmed: 17451830
Nat Commun. 2022 Aug 24;13(1):4958
pubmed: 36002453
Nat Struct Mol Biol. 2016 Oct;23(10):899-905
pubmed: 27617430
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Nature. 2020 Jul;583(7818):830-833
pubmed: 32380511
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):
pubmed: 33335073
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Nature. 2020 Oct;586(7830):560-566
pubmed: 32854108
J Autoimmun. 2020 May;109:102434
pubmed: 32143990
Cell Mol Immunol. 2022 Feb;19(2):293-295
pubmed: 35017716
Nat Commun. 2022 May 27;13(1):2988
pubmed: 35624123
Nature. 2022 Aug;608(7923):603-608
pubmed: 35790190
Structure. 2022 Oct 6;30(10):1432-1442.e4
pubmed: 35917815
Nature. 2022 Mar;603(7902):687-692
pubmed: 35062015
Microbiol Spectr. 2022 Jun 29;10(3):e0178921
pubmed: 35638818
PLoS Biol. 2020 Dec 21;18(12):e3001016
pubmed: 33347434
Commun Biol. 2022 Nov 3;5(1):1170
pubmed: 36329138
Proc Natl Acad Sci U S A. 2022 Nov;119(44):e2206509119
pubmed: 36256797
Science. 2022 Feb 25;375(6583):864-868
pubmed: 35076256
Nature. 2021 Nov;599(7883):114-119
pubmed: 34488225
Cell Host Microbe. 2020 Dec 9;28(6):867-879.e5
pubmed: 33271067
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322
pubmed: 32826334
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Science. 2021 Aug 27;373(6558):968-970
pubmed: 34404734
Cell Discov. 2022 Jul 12;8(1):65
pubmed: 35821014

Auteurs

Dongchun Ni (D)

Laboratory of Biological Electron Microscopy (LBEM), Institute of Physics, School of Basic Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Dep. of Fund. Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Priscilla Turelli (P)

Laboratory of Virology and Genetics (LVG), School of Life Sciences, École polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Bertrand Beckert (B)

Dubochet Center for Imaging (DCI), École polytechnique Fédérale de Lausanne (EPFL) and University of Lausanne, Lausanne, Switzerland.

Sergey Nazarov (S)

Dubochet Center for Imaging (DCI), École polytechnique Fédérale de Lausanne (EPFL) and University of Lausanne, Lausanne, Switzerland.

Emiko Uchikawa (E)

Dubochet Center for Imaging (DCI), École polytechnique Fédérale de Lausanne (EPFL) and University of Lausanne, Lausanne, Switzerland.

Alexander Myasnikov (A)

Dubochet Center for Imaging (DCI), École polytechnique Fédérale de Lausanne (EPFL) and University of Lausanne, Lausanne, Switzerland.

Florence Pojer (F)

Protein Production and Structure Characterization Core Facility (PTPSP), School of Life Sciences, École polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Didier Trono (D)

Laboratory of Virology and Genetics (LVG), School of Life Sciences, École polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Henning Stahlberg (H)

Laboratory of Biological Electron Microscopy (LBEM), Institute of Physics, School of Basic Science, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Dep. of Fund. Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Kelvin Lau (K)

Protein Production and Structure Characterization Core Facility (PTPSP), School of Life Sciences, École polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH